Comprehensive Acyl-CoA & Acylcarnitine Profiling Service
InquiryThe global surge in metabolic disorders has shifted the pharmacological focus toward mitochondrial efficiency and lipid oxidation pathways. Central to this metabolic axis are acyl-coenzyme A (acyl-CoA) and acylcarnitines—critical intermediates that dictate the fate of fatty acids within the cell.
Comprehensive Acyl-CoA & Acylcarnitine Profiling for Anti-Obesity Therapeutics
At Protheragen, we provide a specialized profiling platform designed to accelerate the development of anti-obesity therapeutics. By quantifying these high-energy intermediates, researchers can gain unprecedented insights into mitochondrial "fuel" selection, the efficiency of β-oxidation, and the metabolic bottlenecks that contribute to insulin resistance and adipose tissue expansion. Our service is specifically engineered for preclinical discovery, providing the granular data necessary to validate drug targets and optimize lead compounds in cellular and animal models.
Core Technologies
Protheragen utilizes a sophisticated analytical suite to overcome the inherent instability and low abundance of thioesters and carnitine esters.
- High-Resolution Liquid Chromatography-Mass Spectrometry (LC-HRMS)
We employ state-of-the-art Orbitrap and triple quadrupole systems to ensure sub-picomolar sensitivity.
- Modified Extraction Protocols
To prevent the rapid hydrolysis of short-chain and long-chain acyl-CoAs, our laboratory uses proprietary chilled extraction buffers and immediate derivatization techniques where necessary.
- Targeted Metabolomics Platforms
By using stable isotope-labeled internal standards, we ensure absolute quantification, allowing for direct comparison across different preclinical study cohorts.
- Bioinformatics Integration
Our platform integrates flux analysis data with lipidomic signatures to provide a holistic view of the metabolic landscape affected by novel anti-obesity candidates.
Service Scope
Our profiling service covers a broad spectrum of metabolic intermediates essential for anti-obesity research:
- Acyl-CoA Species
Comprehensive detection from acetyl-CoA and malonyl-CoA (key regulators of fatty acid synthesis and inhibition of oxidation) to succinyl-CoA and long-chain fatty acyl thioesters (C16-C18).
- Acylcarnitine Profiling
Identification of over 40 species, providing a "window" into mitochondrial β-oxidation efficiency and identifying specific enzymatic blocks (e.g., CPT1 or CPT2 inhibition).
- TCA Cycle Intermediates
Optional expanded mapping to correlate acyl-CoA levels with mitochondrial energy production.
- Custom Panels
Specialized focus on branched-chain amino acid (BCAA) derived intermediates, which are increasingly implicated in metabolic syndrome.
Workflow
Our streamlined preclinical workflow ensures data integrity from sample reception to final reporting:
Fields of Application
Our comprehensive acyl-CoA and acylcarnitine profiling service provides the high-resolution metabolic mapping necessary to validate therapeutic efficacy across a diverse range of preclinical obesity and endocrine research models.
- Target Validation: Assessing the impact of inhibiting acetyl-CoA carboxylase (ACC) or activating AMP-activated protein kinase (AMPK).
- Mechanism of Action (MoA) Studies: Determining if a compound promotes "metabolic flexibility" by switching between glucose and lipid oxidation.
- Biomarker Discovery: Identifying specific acylcarnitine signatures in plasma that correlate with reduced adiposity in rodent models.
- Safety and Toxicity: Monitoring for mitochondrial toxicity or incomplete fatty acid oxidation that could lead to lipotoxicity.
Advantages
Choosing Protheragen provides your drug discovery program with a competitive edge:
- Superior Sensitivity
Our methods detect subtle changes in malonyl-CoA levels—often a primary target for anti-obesity drugs—that standard assays frequently miss.
- Matrix Expertise
Metabolic signatures vary wildly across different tissues. We have developed and validated specialized extraction and stabilization protocols for the most challenging preclinical matrices, including brown adipose tissue (BAT), white adipose tissue (WAT), skeletal muscle, and liver.
- Biological Context
We don't just deliver raw data; we provide biological interpretation, helping you understand whether an increase in long-chain acylcarnitines indicates enhanced flux or a metabolic "stall."
- Proven Reliability
We maintain a rigorous benchmark of quality where our high-throughput data demonstrates a high correlation with gold-standard metabolic flux studies (such as 13C-labeling). This ensures that the data you use to make "go/no-go" decisions is both reproducible and biologically sound.
Contact Our Specialists Today to Integrate Our Precision Workflow into Your Next Preclinical Study.
Customer Review
Confirming Target Engagement: Precision Malonyl-CoA Quantification for Lead Optimization
"The team at Protheragen was instrumental in our recent anti-obesity lead optimization phase. Their ability to quantify malonyl-CoA levels in skeletal muscle allowed us to confirm the target engagement of our ACC inhibitors. The data was clean, the interpretation was insightful, and it directly informed our dose-selection for the next round of animal studies."
Dr. B. P., Biopharmaceutical Lead
Overcoming Stability Barriers: Seamless Integration of Specialized Acyl-CoA Extraction Protocols
"Working with Protheragen has been a seamless experience. We previously struggled with the stability of acyl-CoA extracts in-house, but their specialized protocols solved our reproducibility issues. We plan to integrate their acylcarnitine profiling into all our future metabolic health programs."
Dr. D. P., Metabolic Disease Biotech
Frequently Asked Questions
-
Why focus on acyl-CoAs rather than just total fatty acids?
Acyl-CoAs are the "activated" forms of fatty acids; they represent the actual pool available for metabolism, making them more sensitive indicators of drug effect than total lipids.
-
Can you handle very small tissue biopsies from rodent models?
Yes, our high-sensitivity liquid chromatography tandem-mass spectrometry (LC-MS/MS) allows for profiling from as little as 10-20mg of tissue.
-
How do you prevent the degradation of acyl-CoA during shipping?
We provide specific stabilization protocols and require samples to be shipped on dry ice to maintain metabolic "arrest."
-
Is this service suitable for high-throughput screening?
While mass spectrometry is inherently lower throughput than fluorescence, our optimized 96-well extraction format supports large-scale preclinical trials.
-
How does your service compare to standard kits?
Commercial kits often lack the breadth of long-chain species we cover and rarely provide the absolute quantification required for regulatory filings.
-
Can you distinguish between isomers (e.g., isovaleryl-CoA vs. valeryl-CoA)?
Yes, our chromatographic methods are tuned for the separation of critical structural isomers.
-
Do you offer flux analysis using stable isotopes?
We offer customized 13C-labeling studies to complement our steady-state profiling.
-
What is the typical turnaround time?
Most preclinical projects are completed within 3-4 weeks from sample receipt.
-
Can we add other metabolites to the panel?
Absolutely. We often combine this service with organic acid or amino acid profiling.
Contact Us
Protheragen provides a robust, high-sensitivity platform for the absolute quantification of acyl-CoAs and acylcarnitines. Our service is designed to provide deep mechanistic insights into mitochondrial lipid metabolism, supporting the development of next-generation anti-obesity therapeutics in the preclinical phase.
Contact Protheragen for More Information and to Discuss Your Project.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.